Cargando…
Theranostic Role of Iron Oxide Nanoparticle for Treating Renal Anemia: Evidence of Efficacy and Significance by MRI, Histology and Biomarkers
(1) Background: Increasing attention has been given to applying nanosized iron oxide nanoparticles (IOPs) to treat iron deficiency anemia (IDA). Chronic kidney disease (CKD) patients who suffer from IDA often need long-term iron supplements. We aim to evaluate the safety and therapeutic effect of MP...
Autores principales: | Hsiao, Jong-Kai, Chen, Chih-Lung, Hsieh, Wen-Yuan, Kuo, Ko-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301580/ https://www.ncbi.nlm.nih.gov/pubmed/37376162 http://dx.doi.org/10.3390/pharmaceutics15061714 |
Ejemplares similares
-
Magnetically guided theranostics: montmorillonite-based iron/platinum nanoparticles for enhancing in situ MRI contrast and hepatocellular carcinoma treatment
por: Chan, Ming-Hsien, et al.
Publicado: (2021) -
Erlotinib-Conjugated Iron Oxide Nanoparticles as a Smart Cancer-Targeted Theranostic Probe for MRI
por: Ali, Ahmed Atef Ahmed, et al.
Publicado: (2016) -
Iron Oxide Nanoparticles as Theranostic Agents in Cancer Immunotherapy
por: Canese, Rossella, et al.
Publicado: (2021) -
Heparin–Superparamagnetic Iron Oxide Nanoparticles for Theranostic Applications
por: Massironi, Nicolò, et al.
Publicado: (2022) -
MRI-traceable theranostic nanoparticles for targeted cancer treatment
por: Anani, Tareq, et al.
Publicado: (2021)